等待開盤 09-23 09:30:00 美东时间
+0.045
+4.68%
Nautilus Biotechnolgy, Inc.暴升15.59%,报1.03美元
09-16 12:29
今日重点评级关注:富国银行:维持Pyxis Oncology"超配"评级,目标价从12美元升至19美元;Oppenheimer:维持Opus Genetics"跑赢大市"评级,目标价从10美元升至20美元
09-10 15:00
Leerink Partners analyst Puneet Souda initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Outperform rating and announces Price Target of $4.
09-09 23:20
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported $190.000 thousand in sales ...
07-28 18:12
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give...
07-06 18:11
Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter financial results o...
04-28 21:20
Companies Reporting Before The Bell • LGI Homes (NASDAQ:LGIH) is likely to repo...
04-28 19:11
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.17) by 25 percent. This is a 7.69 percent increase over losses of $(0.13) per share
04-28 18:11
U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market trading after beating analyst estimates.
04-09 20:08